Skip to content
Newsletter insight

Zambia and China's Jijia Sign US$213 Million Vaccine Plant Deal

Healthcare & Medical Tourism
Zambia and China's Jijia Sign US$213 Million Vaccine Plant Deal
Zambia's Industrial Development Corporation and China's Jijia signed a joint venture agreement to establish a vaccine manufacturing plant, with planned investment of approximately US$213 million. The first phase is expected to establish a cholera-vaccine facility in Lusaka.
The project creates potential demand for pharmaceutical machinery, laboratory equipment, cold-chain systems and specialist engineering. Healthcare suppliers and technical consultants can explore future manufacturing and operational requirements.
← Back to Business News

Talk to HPC

Discuss this opportunity.

Contact our team about the support available for your business.

💬

Live Message

LIVE
Hello! 👋 How can we help you?
Please write a message first.
✅ Please share your details below
Please enter your name.
Please enter your phone number.
Please select at least one communication method.
✅
Thank you!
We have received your message.
One of our team members will contact you shortly at your preferred communication mode.